help_outline
Skip to main content
Print This Page
Text Size
Scroll To Top
Add Me To Your Mailing List
Member Login
My Shopping Cart
Shopping Cart
cancel
Join MNS
Member Login
Menu
About MNS
Mission Statement
Board of Directors
Committees
By-laws
Advocacy
Past Newsletters
Member Accomplishments
Awards
Contact
MNS Grievance Procedures
Events
Event Calendar
Past Lectures
Science Symposium
Public Resources
What is Neuropsychology?
Building Healthy Brains
Podcasts
Find a Neuropsychologist
General Info Resources
Professional Resources
Diversity Committee
Practice Corner
APA Ethics & Conduct
FABBS
Professional Affairs
Covid-19 Resources
Donate
Contact
Home
Events
The Frontotemporal Lobar Degeneration/ALS Neurodegenerative Disorders Group
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Events
- Event View
This is the "Event Detail" view, showing all available information for this event. If the event has passed, click the "Event Report" button to read a report and view photos that were uploaded.
Return to Grid View
Show Search
Today
The Frontotemporal Lobar Degeneration/ALS Neurodegenerative Disorders Group
When:
Tuesday, January 10, 2023, 7:00 PM until 9:00 PM
Videoconference information will be provided in an email once payment is received.
Additional Info:
Category:
Webinars
Registration is required
Payment In Full In Advance Only
Cancellation Policy:
Capacity:
0
Available Slots:
0
Filled
Guest
$40.00
Member
$30.00
Student
No Fee
Add to my Calendar
What is this?
Doug Watt, PhD, Forensic Neuropsychologist and Behavioral Neuroscientist, Adjunct Professor - Lesley University Graduate School of Psychology
In this webinar we will explore the confusing and complex umbrella concept of the frontotemporal dementia family, which has recently united with the ALS group. This super-category thus includes an enormous spectrum of clinical phenotypes: progressive supranuclear palsy, corticobasal degeneration, two primary progressive aphasias, the classic behavioral variant frontotemporal dementia, LATE, ALS and more. This umbrella concept of FTLD/ALS thus forms the largest, most confusing, and most diverse family of neurodegenerative disorders. Therapeutic opportunities in FTLD-ALS remain largely undefined, beyond modestly successful symptomatic psychopharmacologic approaches. Many more questions than answers, but yet despite this, there has been enormous and encouraging progress in the last 10-15 years. Join Dr. Watt as he discusses FTD and sheds light on the mysteries surrounding it.
1/10/2023 7-9 PM (EST)